A few weeks back, and in fact the day before the U.S. election, RNAi biotech Arrowhead quietly posted some miserable news that its hep B candidate, ARC-520,…

Sanofi has assumed responsibility for Warp Drive Bio's aminoglycoside antibiotic program.

Boehringer teams up with a Chinese research group to tackle disabling hearing loss, which affects millions of people worldwide.

AstraZeneca’s biologics arm MedImmune and synthetic biology co Abpro have joined forces on a new Ang2-VEGF research collab that will come together under a new…

Nivalis saw more than half its value wiped out after hours last night in reaction to the news that its cystic fibrosis candidate did not hit its targets,…

Osaka-based Santen has seen some positives mixed with some negatives for its phase 3 ophthalmology program, but believes it has enough to warrant an NDA with…

GlaxoSmithKline starts pivotal trials of oral red cell stimulator daprodustat as it tries to catch lead rival FibroGen.

Kymab has raised $100 million (€94 million) to fund the advance of its lead candidates into the clinic. The Series C round, which attracted new Chinese…

R&D